Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP934981.RAjHANGvyzS7yVk_psf5P8WNPU19K_RYIYda_TqOYGjI0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP934981.RAjHANGvyzS7yVk_psf5P8WNPU19K_RYIYda_TqOYGjI0130_assertion type Assertion NP934981.RAjHANGvyzS7yVk_psf5P8WNPU19K_RYIYda_TqOYGjI0130_head.
- NP934981.RAjHANGvyzS7yVk_psf5P8WNPU19K_RYIYda_TqOYGjI0130_assertion description "[The aims of this study were (i) to observe the expression of ATR, WWOX and FHIT proteins in urothelial carcinoma (UC) between endemic and non-endemic areas of blackfoot disease (BFD) by immunohistochemical analyses; (ii) to compare expression of these genes between arsenite-treated SV-HUC-1 human epithelial cells and rat uroepithelial cells; and (iii) to determine the role of DNMT and MEK inhibitors on expressions of WWOX and FHIT in response to arsenite in SV-HUC-1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP934981.RAjHANGvyzS7yVk_psf5P8WNPU19K_RYIYda_TqOYGjI0130_provenance.
- NP934981.RAjHANGvyzS7yVk_psf5P8WNPU19K_RYIYda_TqOYGjI0130_assertion evidence source_evidence_literature NP934981.RAjHANGvyzS7yVk_psf5P8WNPU19K_RYIYda_TqOYGjI0130_provenance.
- NP934981.RAjHANGvyzS7yVk_psf5P8WNPU19K_RYIYda_TqOYGjI0130_assertion SIO_000772 23618899 NP934981.RAjHANGvyzS7yVk_psf5P8WNPU19K_RYIYda_TqOYGjI0130_provenance.
- NP934981.RAjHANGvyzS7yVk_psf5P8WNPU19K_RYIYda_TqOYGjI0130_assertion wasDerivedFrom befree-20140225 NP934981.RAjHANGvyzS7yVk_psf5P8WNPU19K_RYIYda_TqOYGjI0130_provenance.
- NP934981.RAjHANGvyzS7yVk_psf5P8WNPU19K_RYIYda_TqOYGjI0130_assertion wasGeneratedBy ECO_0000203 NP934981.RAjHANGvyzS7yVk_psf5P8WNPU19K_RYIYda_TqOYGjI0130_provenance.